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Background: Communication of the diagnosis of MND is daunting for patients and 
neurologists.  
 
Objectives: To establish a knowledge base of current Australian practice of breaking the 
news of an MND diagnosis, to assess the neurologists’ educational and training needs, to 
compare the feedback obtained from neurologists and patients to international practice 
guidelines.  
 
Methods:  An anonymous survey of neurologists was undertaken in Australia (2014). 
 
Results: Completed surveys were received from 73 neurologists (50.4% response rate). 
Nearly 70% of neurologists reported finding it “somewhat to very difficult” communicating the 
MND diagnosis, and 65% reported feeling moderate to high stress and anxiety at the 
delivery of diagnosis. Compared to international guidelines, areas for improvement include 
length of consultation, period of follow up and referral to MND associations. Two thirds of 
neurologists were interested in further training to respond to patient’s emotions and 
development of best practice guidelines.  
 
Conclusions: This is the first national study to provide a comprehensive insight into the 
process of delivering the MND diagnosis from the neurologists’ perspective and to make 
comparisons with those of patients and the international guidelines. This study forms the 
basis for developing protocols to improve communication skills and alleviate the emotional 
burden associated with breaking bad news. 
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Receiving a diagnosis of MND is a challenge and a source of dissatisfaction for patients and 
their families [1-4]. The manner in which the diagnosis is given has implications for the way 
patients and families move from the news of their diagnosis to the actions required for 
support throughout the illness trajectory [5, 6] and bereavement response [7]. 
 
Despite these findings, few studies have focussed on neurologists breaking the MND 
diagnosis to patients. A recent investigation of 25 neurology residents in the US showed that 
68% thought that breaking the diagnosis was stressful, 45% were not confident they were 
communicating the diagnosis effectively, and only 9% agreed they had received adequate 
training [8]. Additionally, analyses of video recordings of the same residents breaking the 
diagnosis to a patient indicated room for improvement, especially in demonstrating empathy 
and communication skills. The neurology residents made several suggestions for further 
training (e.g., practice guidelines), practice opportunities, and skills development relevant to 
communicating a diagnosis of MND. These findings correspond with studies showing that 
physicians report the delivery of bad news is a stressful experience [9,10] yet overlooked in 
their training [11]. These findings point to the importance of appropriate training and 
supervision opportunities, as well as the development and use of guidelines and protocols 
for the delivery of bad news. 
 
The SPIKES protocol is a well-accepted system for communicating bad news [12]. The 
protocol recommends the health professional establish an appropriate Setting, determines 
the needs and Perceptions of the patient, requests an Invitation to give the news, provides 
Knowledge and information to the patient, explores the patient’s feelings and responds 
Empathetically, and forms a Strategy with the patient to go forward. A similar set of 
guidelines for communicating with adult patients with advanced life-limiting illnesses and 
their caregivers was developed in Australia [13]. 
 
Given the absence of controlled trials of communicating the MND diagnosis, the American 
Academy of Neurology [14] concluded there was insufficient evidence supporting any 
particular method and noted that useful strategies have been developed for communicating 
a diagnosis of cancer. Best practice guidelines for MND in the United Kingdom [15] stress 
the need for support for patients and family carers from diagnosis so that the individual’s 
spiritual and emotional needs may be addressed alongside medical and practical needs. 
Further, their standards of care emphasise that people living with MND require sensitive 
communication of the diagnosis combined with appropriate information about MND and 
support services, ensuring the provision of emotional/psychological support, a follow-up 
appointment within two weeks of diagnosis, and direct referral to the relevant MND 
association. Similarly, clinical practice guidelines developed in Europe [16, 17] promote the 
communication of the diagnosis by a consultant neurologist with a good knowledge of the 
patient. The neurologist should begin by asking what the patient already knows or suspects. 
The diagnosis would be given in person with time available for discussion (at least 45–60 





advocacy groups, and a summary of the discussion. Patients should be reassured that they 
will have regular follow-up visits to a neurologist within 2-4 weeks of diagnosis and 
supported by a specialist MND care team, where available. The neurologist should avoid 
withholding the diagnosis, providing insufficient or unwanted information, and communicating 
in a manner that is callous or removes hope. 
 
Multidisciplinary MND clinics are considered to provide best practice coordinated care from 
the time of diagnosis, where specialist MND care teams deliver integrated services dealing 
with neurology, rehabilitation and palliative care. They have well established links to MND 
associations [14,18] and care is supported by regular decisions about symptom 
management and quality of life as the patient’s condition deteriorates [19]. 
 
Reducing the physician’s emotional burden associated with breaking bad news and the 
development of skills in communicating bad news are increasingly recognized as priorities in 
medical education [8]. To date, there are no Australian guidelines for communicating a 
diagnosis of MND and there is limited information about how neurologists actually 
communicate the diagnosis in Australia and elsewhere and the nature and extent of the 




This study aims to inform best practice in breaking bad news in the MND field. The specific 
objectives of this article were to: 
1) Determine the current practice of neurologists in breaking the news of an MND 
diagnosis in Australia 
2) Assess the neurologists’ educational and training needs related to breaking bad 
news and responding to patients’ emotions  
3) Compare the neurologists’ experience to that of patients undertaken in a separate 
survey in the same year (2014) 
4) Assess the current practice of neurologists in breaking news in comparison to 








The development of the questionnaire was undertaken after a comprehensive review of the 
international literature in this field and with extensive consultation with clinicians and the 
MND associations in Australia. Moreover, the questions included in the sections on 
consultations and follow up were constructed to align with the international guidelines, where 





Australian and New Zealand Association of Neurologists (ANZAN) e-bulletin and website (by 
liaising with ANZAN secretariat). It was also advertised in the ANZAN scientific meeting in 
May 2014. The survey was made available to be completed on-line by clicking a link in the e-
bulletin that goes to ANZAN members. The three neurologists on the research team trialled 
this version and gave comments before it was made generally available. However, in order 
to improve the response rate, it was also necessary to do mail-outs based on lists provided 
by the MND associations in every Australian state. The neurologists’ survey comprised 45 
questions grouped in five sections: Demographics; how patients’ consultations were 
conducted; the communication plan and support for patients; the personal experiences in 
giving the diagnosis; and the neurologists’ education and training needs and interest in 
developing best practice guidelines. 
 
Patients’ survey  
The methods for the patients’ parallel survey were reported in Aoun et al (2015) [4]. The 
reported practice of Australian neurologists was compared to those reported by patients and 
addressed in the results section of this article. For every guideline, reports from both groups 




Frequencies and proportions were calculated for categorical variables, and mean, standard 
deviation, median and range were computed for continuous and discrete variables. 
Neurologists’ practices were analysed as a comparison according to whether they practice in 
an MND multidisciplinary clinic (MDC) or not. This comparison could only be undertaken in a 
few areas due to the sample size of those in MDCs (n=11). The analysis was largely 
descriptive and the inferential comparisons included were those that can be compared with 
the international guidelines. Non-parametric tests were used for the comparisons due to the 
small sample sizes. Fisher’s Exact Test was used for categorical variables and Mann-
Whitney U for continuous variables. The statistical correction for multiple tests is Bonferroni’s 





Seventy-three neurologists responded to the survey corresponding to a 50.4% overall 
response rate, and corresponding to 80% of neurologists who work in dedicated MDCs. The 
response rate was based on the lists provided by the MND associations in Australia, as the 
link in the e-bulletin was not favoured. Four respondents were not included in the analysis as 









The mean age of respondents was 52.7 years (SD=10.3), 78% were male, median length of 
practice was 20 years (range 1-44), 90% trained in Australia, 16% (n=11) worked in a MDC 
and saw a median number of 10 new patients per year (range 5 to 80). Non-MDC 
neurologists saw a median of 5 patients per year (range 1 to 15). The median number of 
current patients was 45 for MDC neurologists (range 4 to 100) and 3 for non-MDC 




The median period between first clinical consultation and diagnosis was four weeks (range 
1-26), and 68% of neurologists reported requiring two consultations to convey the diagnosis. 
The difference in consultation times was significant between the two groups (p<0.001): a 
mean of 23 minutes for non-MDC and twice longer for those in MDC (45 minutes) (Table 1). 
78% of neurologists were always able to give the diagnosis in a private space and 41% 
always able to avoid interruptions. 75% tended to refer for a second opinion. While 98% of 
neurologists reported having a relative present during the diagnosis, 23% of them reported 
that on some occasions they have seen patients alone, with a difference between the two 
settings, although not significant (MDC=9%, non-MDC=26%) (Table 1). 80% of neurologists 
did not have any particular day of the week and timing they would refrain from giving the 
diagnosis (such as Friday afternoon). 
 
At the time of giving the diagnosis, the most discussed clinical aspects pertain to: the degree 
of certainty of the diagnosis (94%), the course/prognosis of the disease (93%) and how the 
diagnosis was reached (91%). 
 
Follow up support  
 
Follow up support was always initiated by 68% of respondents within 4 weeks from 
diagnosis (range 1-12) with subsequent follow ups of 12-weeks interval (range 4-26); 73% 
reported referring to an MND association for information and ongoing support. However, 
referral to an MND association was significantly higher for those in MDC (100%) compared 
to non-MDC (67%) (p=0.028) (Table 1). 
 
The follow up support was mainly provided by the neurologist (MDC=91% and non-
MDC=72%); followed in non-MDC settings by the GP (40%), the MND association (31%) 
and then a specialist nurse (17%). However, in MDC settings, the GP took a lesser role 
(18%) and more of the support was provided by the MND association (55%) and the 
specialist nurse (36%) (Table 1).  
 











Delivery of diagnosis (2 or more consults) 55% 83% 0.052 
Length of consultation (minutes) 45 23 0.001 
Private space (yes - always/frequently) 100% 96.6% 1.000 
Avoid interruptions (yes - always/frequently) 91% 91% 0.579 
Patient seen alone 9% 26% 0.436 
Referral to MND Association for information 
and ongoing support 
100% 67% 0.028 
MND Association publications given 64% 40% 0.190 
Diagnosis in writing 27% 21% 0.694 
Follow-up support: Neurologist 91% 72% 0.270 
Follow-up support: MND Association 55% 31% 0.172 
aComparison between MDC and non-MDC neurologists completed with Fisher’s Exact Test 
for categorical data and Mann-Whitney U Test for continuous data. 
 
Personal experiences in giving the diagnosis 
 
About 70% of neurologists found communicating the diagnosis “very to somewhat difficult”, 
43% found it “very to somewhat difficult” responding to patients’ and/or their family members’ 
reactions and 65% experienced “high to moderate” stress and anxiety at the diagnosis 
delivery (Figs 1 - 3). 
 
Fig 1: Level of difficulty in communicating an MND diagnosis 
Fig 2: Level of difficulty in responding to patient's and/or their family member's 
reactions (e.g., crying, anger, disbelief) 
 
Fig 3: Level of stress and anxiety experienced during the delivery of the diagnosis. 
 
The most difficult parts of discussing the news of an MND diagnosis related to: Being honest 
but not taking away hope (80%); dealing with the patient’s emotion (38%) and spending the 
right amount of time (28%). The reasons for experiencing these difficulties included the lack 
of an effective treatment (77%), fear of causing distress (36%) and fear of not having all the 
answers (20%). One neurologist expressed such feelings: “Having had a migraine after each 
MND clinic, feeling stressed and anxious about having so little to offer, I have gradually 
accepted the limitations of my skills, and some confidence that assisting the patients 
honestly and empathetically, and not ‘abandoning’ them is of value to most patients.” (P47) 
 
Education and Training Needs 
 
When asked whether neurologists had training in “techniques of responding to patient’s 
emotions”, 44% had no training, and 28% had learnt from sitting in with clinicians. However, 





techniques. There were some differences between those interested/somewhat interested 
(n=50) and those not interested (n=18) in further training in techniques of responding to 
patient’s emotions: 
             -interested neurologists in further training had been practicing for a shorter period of 
time (median 17 years) compared to those not interested (median 26 years), although the 
difference was not significant; 
            -more of the interested neurologists had found it difficult/somewhat difficult 
communicating the MND diagnosis compared to those not interested (76% vs 47%, 
p=0.049) and more of the interested neurologists had found it difficult/somewhat difficult 
responding to patients’ reactions compared to those not interested (55% vs 11%, p<0.001); 
 
However, one neurologist was dubious about the value of education: “Diagnosing MND is  
always unpleasant for both patient and physician... I think many physicians don’t deliver the 
news well but I don’t believe it is something that can be taught….  Perhaps we should be 
selecting junior doctors to enter physician training on the basis of their communication skills? 
The science is easily learned. Trying to teach empathy, sincerity, and understanding is 
impossible. Selecting for those qualities is easy.” (P52) 
 
Development of Best Practice Guidelines 
 
When asked whether neurologists had “specific training in giving an MND diagnosis”, 54% 
had received no specific training and 23% had sat in with clinicians. Respondents were very 
interested (38%) to somewhat interested (44%) in having best practice guidelines 
developed. There were some differences between those interested/somewhat interested 
(n=56) and those not interested (n=12) in the development of best practice guidelines: 
             -interested neurologists in development of best practice guidelines had been 
practicing for a shorter period of time (median 19 years) compared to those not interested 
(median 27 years), although the difference was not significant. 
            -interested neurologists tended to have a longer consultation time to deliver the 
diagnosis compared to those not interested (30 vs 18 minutes, p=0.053). 
            -More of the interested neurologists had found it difficult/somewhat difficult 
responding to patients’ reactions compared to those not interested (46% vs 33%, p=0.019). 
 
Comparison with patient feedback 
 
The key comparisons between the two parallel surveys of patients and neurologists are 















Table 2: Neurologists’ reported practice in delivering the diagnosis compared to the 








 N=245 n=69  
Diagnosis by neurologist 95% - Always 
Delivery of diagnosis (2 or more consults) 70% 78% step-wise 
Length of consultation (minutes) 30 20 45-60 mins 
Private space (yes - always/frequently) 96% 97.1% Always 
Avoid interruptions (yes - always/frequently) 91% 91% Always 
Patient seen alone 21% 23% Never 
Referral to MND Association for information and 
ongoing support 
40% 73% Always 
MND Association publications given 24% 44% Always 
Diagnosis in writing 16% 22% recommended 
Enough information given 43% - Always 
Asked of any previous MND knowledge 43% - Always 
Follow-up support: Neurologist 41% 75% Always 
Follow-up support: MND Association 56% 35% Always 
Diagnosis to follow-up (median, weeks) 7  4  2-4 weeks 
Diagnosis given with warmth, care & empathy 67% - Always 
Sufficient time to express emotions 63% - Always 
Sufficient time to have emotions responded to 62% - Always 
 
 
Seventy-eight percent of neurologists reported that they deliver the diagnosis in a stepwise 
fashion in two or more consultations, and 22% in one consultation. This is nearly comparable 
to 70% of patients reporting that they had at least two visits to receive the diagnosis [4]. The 
stepwise process of delivering the news is described as follows by one neurologist: “My 
practice was to let the patient know that their condition was of concern as soon as MND 
appeared likely (e.g., at 1st consultation) and continue to prepare patient in subsequent 1-2 
consults before giving the news without taking away hope.” (P16) 
 
Neurologists reported that in most cases a relative was present when they communicated 
the diagnosis, but on some occasions, 23% of neurologists saw the patient alone. This is 
comparable to 70% of patients reporting having a relative present with them with 21% 






Neurologists reported that the time spent with the patient to deliver the diagnosis was 20 
minutes, however the length of consultation was twice as long in multidisciplinary MND 
clinics (Table 1). Seventy percent of neurologists reported having some level of difficulty 
finding enough time to discuss the diagnosis. Patients reported a median consultation time 
of 30 minutes and 70% of them felt they had sufficient time to receive the diagnosis.  
Patients who rated highly the ability of their neurologists had significantly longer consultation 
times (40 vs 30 minutes, p<0.001), and felt they had enough time to receive the diagnosis 
(84% vs 48%, p<0.001) [4]. 
 
Regarding information, support and advocacy, 73% of neurologists reported providing 
information about and referred to MND associations, 44% gave MND associations’ 
publications and 22% the diagnosis in writing. However only 42% of patients reported 
receiving information on MND associations, 24% MND association publications, 40% referral 
to an MND association and 16% the diagnosis in writing [4]. 
 
Concerning plans for follow-up, half of the neurologists ‘always’ encouraged patients to 
contact them if they have additional concerns. After receiving the diagnosis, 56% of patients 
reported that they were supported by an MND association, 42% by their GP, 41% by the 
neurologist, 28% by the MND clinic and 27% by the MND nurse [4]. Only 2.4% reported not 
being supported. Follow up support was always initiated by 68% of neurologists within a 
median 4 weeks from diagnosis (range 1-12 weeks). However, patients reported a median of 
7 weeks for the first follow up visit after the diagnosis (range 1-52 weeks). Both neurologists 
and patients reported that the median interval between follow-ups was 12 weeks. In addition, 
80% of neurologists did not report that they have a best day or time to deliver the diagnosis. 
 
When it came to the setting, 78% of neurologists always gave the diagnosis in a private 
space, 41% always avoided interruptions. The majority of patients (96%) reported that the 
diagnosis was given in a completely private space/environment; and the majority (91%) had 





This is the first national Australian study to provide a comprehensive insight into the process 
of breaking the MND diagnosis from the neurologists’ perspective, considering responses 
came from half of the neurologists in the country. This sample size is comparable to that of a 
European study conducted in 2001, where 73 neurologists from MDCs responded (66% 
response rate) to a wider survey on ALS clinical management and terminal care (20).  
However, our study had 80% response rate from neurologists in MDCs.  
 
Several aspects of good practice are met in Australia from the evidence reported by the two 
groups (neurologists and patients) in comparison to international guidelines. Table 2 
summarises the key comparisons that align to the international guidelines. As 





a neurologist in Australia, and the majority of neurologists reported delivering the diagnosis 
in a stepwise fashion. However, there is room for improvement in first ascertaining what the 
patient and family understand as only 43% of people with MND reported being asked how 
much they knew about their condition and 43% were given just enough information [4]. This 
would clarify the patients’ understanding of their current situation and the context in which 
decisions about goals of care are to be made. 
 
There is also scope for improvement in responding empathically to the feelings of 
patient/family when 30-40% of patients highlighted a gap in this skill, and a considerable 
proportion of neurologists reported difficulties in this domain. In particular, the largest 
significant difference between the two groups of neurologists (high and low ratings of skills) 
was in empathy as it was seen as an important attribute of highly skilled neurologists [4]. 
 
As recommended, the diagnosis is nearly always given in person. The Australian practice of 
communicating the diagnosis in 20 to 30 minutes falls short of the recommended guideline of 
45 to 60 minutes. There needs to be a commitment to take more time to deliver the 
diagnosis and have 45-60 minutes available. It is evident that the longer the patients spent 
with their neurologists during breaking the diagnosis, the more they were satisfied with the 
delivery process and the higher they rated the neurologists’ ability/skills [4]. There is room for 
improvement in making sure patients are not seen alone and are advised to have a support 
person with them when receiving the diagnosis. 
 
There needs to be a routine practice for all neurologists to refer to MND associations (as per 
the European guidelines), as 27% of neurologists did not refer and 60% of patients reported 
not being referred. In addition, it would be useful if all neurologists gave the diagnosis in 
writing as this would help the patient and family communicate the diagnosis to support 
organisations (such as the MND associations) and health professionals involved in their 
care. 
 
As recommended, patients were supported by a range of health professionals. The 
Australian practice of a close follow up visit of 4-7 weeks from diagnosis falls short of the 
recommended guideline within 2-4 weeks or sooner. In addition, it was interesting to find out 
that the vast majority of neurologists did not mention that, for example, Friday afternoons 
were not appropriate to deliver the diagnosis where there was little opportunity for patient 
support at the weekend. 
 
Although there were a few respondents from MDCs to make meaningful comparisons, 
findings point to the practice of neurologists involved in MDCs being more aligned with the 
international guidelines in terms of length of consultation and other indicators listed in Table 
1. Borasio et al [20] highlighted that standards are usually higher in areas with specialized 
ALS centres in Europe. In a recent Australian study [21, 22], specialized multidisciplinary 
MND care was found to facilitate patient engagement with clinicians in decision-making by 
providing an optimal environment for information provision, support, and planning, stability 
and care continuity. One neurologist in this study commented that: “The major issue is lack 





very difficult as a neurologist in private practice to coordinate and access the 
multidisciplinary care required esp. for patients who live at a distance”. (P45) 
 
The feelings of stress and anxiety associated with delivering the diagnosis are comparable 
to those reported in the literature [8,11]. However, it is worth noting that the impact of 
delivering a diagnosis may be milder or more severe depending on the types of MND and 
the prognostic differences between them. While the neurologists’ survey did not collect such 
information, the findings from the patients’ survey indicate that 69% reported having 
cervical/lumbar symptoms at onset, 19% had bulbar symptoms and the rest a combination of 
symptoms [4]. Although the two anonymous surveys were undertaken in the same year, we 
cannot ascertain how many of the responding neurologists were involved with the patients in 
the parallel survey. 
The needs for education and training in communicating the diagnosis are comparable to 
those reported in the literature [8,11]. Essentially, two thirds of responding neurologists 
(46/68) were interested in both further training responding to patients’ emotions and 
development of best practice standards. It is worth noting, and perhaps expected, that those 
interested had reported more difficulty in communicating the diagnosis.  Therefore, it is 
recommended that the peak bodies (MND Australia and ANZAN) consider education and 
training programs aimed at improving the skills of neurologists and neurology trainees in 
responding to patients’ emotions, based on the evidence from this study. It is also 
recommended that these two peak bodies develop MND specific best practice standards in 




Limitations include that the questionnaire was not validated other than by consensus from 
experts that included three neurologists, a palliative care physician, two nurses, a 
psychologist and representatives from MND associations. However, the questions included 
in the sections on consultations and follow up were constructed to align with the international 
guidelines where possible. Due to the anonymous nature of both patient and neurologist 
surveys, we could not ascertain how many of the responding neurologists were involved with 
patients in the parallel survey. Therefore, the comparative analysis between the two groups 
was descriptive, and those indicators aligned with the international guidelines were mainly 
included.  
 
There may have been a selection bias and those neurologists who see only a few MND 
patients may have had a less stressful experience and therefore may have opted not to 
participate. However, it was intentional to include neurologists with a frequent experience 
with the disease, as the introductory part of the questionnaire had a statement that said: “If 
the number of patients in questions 7 (number you diagnose per year) and 8 (number you 
currently care for) is zero, then there is no need to proceed with the rest of the questionnaire 





consisted of older and experienced neurologists (median length of practice of 20 years), with 
possibly the findings not reflecting the experience faced by "young" neurologists. 
 
As this article reported on many aspects of delivering the diagnosis, it was deemed 
impractical to incorporate a theoretical framework for every aspect. Future qualitative articles 
from this study will focus on single aspects with corresponding theoretical frameworks, 
where appropriate.  
 
Conclusion 
To our knowledge, this is the first study to take into account the perspectives of both 
neurologists and patients and to address an important knowledge gap in the clinical care of 
individuals with MND. This study added to our understanding of the process of delivering a 
diagnosis of MND and the pressures it placed on neurologists in terms of stress and anxiety. 
The comparison between neurologists' experiences and those of patients provided a novel 
view of the topic. Interpreting the findings in relation to accepted international guidelines for 
care provided a sound benchmark against which to judge the extent to which neurologists in 
Australia are achieving recognised standards and pointed to areas in need of improvement. 
We believe that this study has filled a gap in the literature as one respondent expressed the 
following remark which was representative of many: “I am glad that you are doing this 
questionnaire. I think that more research needs to be done in this area - so well done! Happy 
to support in any way I can” (P17). This study could form the basis for improving practice to 
alleviate the emotional burden associated with breaking bad news as poor communication 
increases the risk of burnout and fatigue [5]. This is achievable by the two peak bodies in 
MND and Neurology, MNDA and ANZAN, instigating educational programs and developing 
standards and protocols with applicability at the international level.  
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